Stay updated on Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.

Latest updates to the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page
- Check6 days agoChange DetectedDifference0.1%

- Check13 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check20 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1 with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThis update adds a glossary display, updates labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and changes the revision to v3.4.0, while removing the prior labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the previous revision v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedRemoved core study documents including the Informed Consent Form and the Study Protocol/Statistical Analysis Plan from the page’s downloadable documents.SummaryDifference20%

- Check42 days agoChange DetectedFooter revision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.